{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:18:22Z","timestamp":1786659502752,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,8]]},"DOI":"10.7759\/cureus.68946","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T18:13:49Z","timestamp":1725819229000},"source":"Crossref","is-referenced-by-count":2,"title":["Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD)-Monophasic Optic Neuritis and Epstein-Barr Virus (EBV): A Case Report of Rare Comorbid Diagnoses in an Adolescent From a Remote Greek Island"],"prefix":"10.7759","author":[{"given":"Efstratia-Maria","family":"Georgopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Palkopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Liakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kerazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos-Michail","family":"Kalaentzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Barmparoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Kokkinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kaliontzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Anagnostouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30432-4","article-title":"Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care","volume":"20","author":"Fadda G","year":"2021","unstructured":"Fadda G, Armangue T, Hacohen Y, Chitnis T, Banwell B. Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. Lancet Neurol. 2021, 20:136-49. 10.1016\/S1474-4422(20)30432-4","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell B","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al.. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 2023, 22:268-82. 10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik K","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, et al.. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022, 375:296-301. 10.1126\/science.abj8222","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200275","article-title":"MOG CNS autoimmunity and MOGAD","volume":"11","author":"Moseley CE","year":"2024","unstructured":"Moseley CE, Virupakshaiah A, Forsthuber TG, Steinman L, Waubant E, Zamvil SS. MOG CNS autoimmunity and MOGAD. Neurol Neuroimmunol Neuroinflamm. 2024, 11:e200275. 10.1212\/NXI.0000000000200275","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05623-1","article-title":"Clinical characteristics of Epstein-Barr virus infection in the pediatric nervous system","volume":"20","author":"Cheng H","year":"2020","unstructured":"Cheng H, Chen D, Peng X, Wu P, Jiang L, Hu Y. Clinical characteristics of Epstein-Barr virus infection in the pediatric nervous system. BMC Infect Dis. 2020, 20:886. 10.1186\/s12879-020-05623-1","journal-title":"BMC Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53488-0.00013-4","article-title":"Epstein-Barr virus infections of the nervous system","author":"Tselis AC","year":"2014","unstructured":"Tselis AC. Epstein-Barr virus infections of the nervous system. Handbook of Clinical Neurology. Elsevier, Amsterdam, Netherlands; 2014. 123:285-305. 10.1016\/B978-0-444-53488-0.00013-4"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmod.2020.01.001","article-title":"Epstein-Barr virus infection in the development of neurological disorders","volume":"32","author":"Soldan SS","year":"2020","unstructured":"Soldan SS, Lieberman PM. Epstein-Barr virus infection in the development of neurological disorders. Drug Discov Today Dis Models. 2020, 32:35-52. 10.1016\/j.ddmod.2020.01.001","journal-title":"Drug Discov Today Dis Models"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417151","article-title":"Epstein-Barr virus and human endogenous retrovirus in Japanese patients with autoimmune demyelinating disorders","volume":"24","author":"Cossu D","year":"2023","unstructured":"Cossu D, Tomizawa Y, Sechi LA, Hattori N. Epstein-Barr virus and human endogenous retrovirus in Japanese patients with autoimmune demyelinating disorders. Int J Mol Sci. 2023, 24:17151. 10.3390\/ijms242417151","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26062","article-title":"Multiple sclerosis is rare in Epstein-Barr virus-seronegative children with central nervous system inflammatory demyelination","volume":"89","author":"Nourbakhsh B","year":"2021","unstructured":"Nourbakhsh B, Cordano C, Asteggiano C, et al.. Multiple sclerosis is rare in Epstein-Barr virus-seronegative children with central nervous system inflammatory demyelination. Ann Neurol. 2021, 89:1234-9. 10.1002\/ana.26062","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/children8100855","article-title":"Pediatric optic neuritis: description of four cases and review of the literature","volume":"8","author":"Presicci A","year":"2021","unstructured":"Presicci A, Serra M, Achille M, Caputo E, Margari L. Pediatric optic neuritis: description of four cases and review of the literature. Children (Basel). 2021, 8:855. 10.3390\/children8100855","journal-title":"Children (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03108-y","article-title":"MOG antibody-associated optic neuritis","volume":"38","author":"Jeyakumar N","year":"2024","unstructured":"Jeyakumar N, Lerch M, Dale RC, Ramanathan S. MOG antibody-associated optic neuritis. Eye (Lond). 2024, 38:2289-301. 10.1038\/s41433-024-03108-y","journal-title":"Eye (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076156","article-title":"Epstein-Barr virus reactivation as a new predictor of achieving remission or lupus low disease activity state in patients with systemic lupus erythematosus with cutaneous involvement","volume":"24","author":"Miskovic R","year":"2023","unstructured":"Miskovic R, Cirkovic A, Miljanovic D, et al.. Epstein-Barr virus reactivation as a new predictor of achieving remission or lupus low disease activity state in patients with systemic lupus erythematosus with cutaneous involvement. Int J Mol Sci. 2023, 24:6156. 10.3390\/ijms24076156","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51759","article-title":"Attack phenotypes and disease course in pediatric MOGAD","volume":"10","author":"Santoro JD","year":"2023","unstructured":"Santoro JD, Beukelman T, Hemingway C, Hokkanen SR, Tennigkeit F, Chitnis T. Attack phenotypes and disease course in pediatric MOGAD. Ann Clin Transl Neurol. 2023, 10:672-85. 10.1002\/acn3.51759","journal-title":"Ann Clin Transl Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10097-x","article-title":"Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis","volume":"268","author":"Vicini R","year":"2021","unstructured":"Vicini R, Br\u00fcgger D, Abegg M, Salmen A, Grabe HM. Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis. J Neurol. 2021, 268:276-84. 10.1007\/s00415-020-10097-x","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12585-w","article-title":"Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes","author":"Manzano GS","year":"2024","unstructured":"Manzano GS, Levy M, Salky R, et al.. Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes. J Neurol. 2024, 10.1007\/s00415-024-12585-w","journal-title":"J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209321","article-title":"Validation of the 2023 international diagnostic criteria for MOGAD in a selected cohort of adults and children","volume":"103","author":"Varley JA","year":"2024","unstructured":"Varley JA, Champsas D, Prossor T, et al.. Validation of the 2023 international diagnostic criteria for MOGAD in a selected cohort of adults and children. Neurology. 2024, 103:e209321. 10.1212\/WNL.0000000000209321","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1137998","article-title":"Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease","volume":"14","author":"Corbali O","year":"2023","unstructured":"Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol. 2023, 14:1137998. 10.3389\/fneur.2023.1137998","journal-title":"Front Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.679770","article-title":"Regulatory T cells increase after rh-MOG stimulation in non-relapsing but decrease in relapsing MOG antibody-associated disease at onset in children","volume":"12","author":"Horellou P","year":"2021","unstructured":"Horellou P, de Chalus A, Giorgi L, et al.. Regulatory T cells increase after rh-MOG stimulation in non-relapsing but decrease in relapsing MOG antibody-associated disease at onset in children. Front Immunol. 2021, 12:679770. 10.3389\/fimmu.2021.679770","journal-title":"Front Immunol"},{"key":"ref19","article-title":"Peripheral blood lymphocyte counts in patients with infectious mononucleosis or chronic active Epstein-Barr virus infection and prognostic risk factors of chronic active Epstein-Barr virus infection","volume":"13","author":"Lin J","year":"2021","unstructured":"Lin J, Chen X, Wu H, Chen X, Hu X, Xu J. Peripheral blood lymphocyte counts in patients with infectious mononucleosis or chronic active Epstein-Barr virus infection and prognostic risk factors of chronic active Epstein-Barr virus infection. Am J Transl Res. 2021, 13:12797-806.","journal-title":"Am J Transl Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103216","article-title":"Treatment of MOG-IgG associated disease in paediatric patients: a systematic review","volume":"56","author":"Klein da Costa B","year":"2021","unstructured":"Klein da Costa B, Banwell BL, Sato DK. Treatment of MOG-IgG associated disease in paediatric patients: a systematic review. Mult Scler Relat Disord. 2021, 56:103216. 10.1016\/j.msard.2021.103216","journal-title":"Mult Scler Relat Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/286475-myelin-oligodendrocyte-glycoprotein-antibody-disease-mogad-monophasic-optic-neuritis-and-epstein-barr-virus-ebv-a-case-report-of-rare-comorbid-diagnoses-in-an-adolescent-from-a-remote-greek-island","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T18:13:54Z","timestamp":1725819234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/286475-myelin-oligodendrocyte-glycoprotein-antibody-disease-mogad-monophasic-optic-neuritis-and-epstein-barr-virus-ebv-a-case-report-of-rare-comorbid-diagnoses-in-an-adolescent-from-a-remote-greek-island"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.68946","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,8]]}}}